ZS Pharma, Inc. — Form D/A

ZS Pharma, Inc. of FORT WORTH, TX, a company, filed a Form D amendment with the SEC on 2012-07-10. The offering totals $5.3M, of which $5.3M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (37)

Showing 25 of 37 people.

NameRoleLocation
Miles B. DavisDirectorFort Worth, TX
Alvaro F. GuillemDirectorFort Worth, TX
Marc B. OstroDirectorFort Worth, TX
Robert B. TruittDirectorForth Worth, TX
Stephen R. AshExecutive OfficerForth Worth, TX
Nels P. BergmarkExecutive OfficerForth Worth, TX
Alvaro F. GuillemExecutive OfficerFort Worth, TX
TIM OPLERDirectorNEW YORK, NY
TIM OPLERExecutive OfficerNEW YORK, NY
Robert B TruittDirectorWest Lafayette, IN
Robert B TruittExecutive OfficerWest Lafayette, IN
Todd B CreechExecutive OfficerCoppell, TX
Donald Jeffrey KeyserDirectorFort Worth, TX
Donald Jeffrey KeyserExecutive OfficerFort Worth, TX
Marc B OstroDirectorCoppell, TX
Cynthia B SmithExecutive OfficerCoppell, TX
John B McKearnDirectorCoppell, TX
Henrick Sandvad RasmussenExecutive OfficerFort Worth, TX
Robert B AlexanderDirectorCoppell, TX
Robert B AlexanderExecutive OfficerCoppell, TX
Nels P BergmarkExecutive OfficerForth Worth, TX
Miles B DavisDirectorFort Worth, TX
William KushnerExecutive OfficerSunnyvale, CA
Joy Sandvad BartonExecutive OfficerForth Worth, TX
Henrik Sandvad RasmussenExecutive OfficerFort Worth, TX

Other filings by this issuer (7)

FiledFormOfferingSold
2014-03-11D$25.0M$25.0M
2012-10-23D$46.0M$27.6M
2011-12-12D/A$4.3M$4.3M
2011-11-22D$4.3M$3.9M
2010-12-20D$792K
2010-12-13D/A$3.0M$1.2M
2009-03-30D$3.0M$282K

More